Fluidigm's Q4 Revenues Grow 60 Percent Aided by DVS Sciences Buy | GenomeWeb

NEW YORK (GenomeWeb) – Fluidigm said after the close of the market on Thursday that its fourth quarter revenues increased 60 percent year over year or 21 percent on an organic basis.

For the three months ended Dec. 31, the South San Francisco, Calif.-based firm reported total revenues of $33.5 million compared to $20.9 million in the year-ago period, just edging out its preannouncement of $33.4 million in revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.